Top Social Impact Companies With Best Stability & Growth (4,137)

Strong Revenue Growth: Public listings like Deloitte’s Technology Fast 500 across multiple years and company disclosures indicating continued momentum into 2024–2026 point to sustained top-line expansion.

Market Expansion: Reports of a London office opening, larger Austin headquarters, and rising global customer reach signal growing geographic footprint and scale.

Product Line Growth: Recent AI-driven launches, the Pyrra acquisition, and partnerships with Riskonnect and Healix broaden the platform into social intelligence and end-to-end travel risk management.

Strong Revenue Growth: Company disclosures indicate Hinge’s direct revenue rose steadily through late 2025 and continued to increase in early 2026. Portfolio commentary links recent outperformance in part to Hinge’s sustained momentum.

Market Expansion: Hinge broadened its footprint across Europe and into Latin America and India, achieving top download ranks in targeted European countries and quickly reaching high positions in Mexico and Brazil. Management outlines continued international rollouts with organic traction preceding full marketing.

Innovation-Driven Growth: The app introduced verification and conversation tools (e.g., Face Check, Convo Starters) that are reported to improve outcomes and safety while supporting monetization. Its “intentional dating” positioning aligns product features with higher‑intent engagement.

Strong Market Position & Advantage: Public materials consistently cite more than 1,300 organizations on the platform, including global pharmas like Merck, Moderna, and Sanofi. This breadth and logo depth indicate entrenched presence across modern biotech R&D.

Innovation-Driven Growth: The company continues launching new capabilities (e.g., Benchling Models, Biologics updates, Validated Cloud) and reports broad uptake of Benchling AI after GA, suggesting expanding use cases across its base. Ecosystem moves like one‑click ordering integrations point to product‑led expansion.

Strong Revenue Growth: Independent estimates describe ARR above $200M in 2024 and increasing year over year. This supports a view of continued top‑line expansion despite a tougher market context.

Investor Backing & Capital Strength: Successive up-rounds (Series C in 2023 and Series D in 2024) with a marked valuation step-up indicate strong investor conviction and ample capital for expansion. Feedback suggests this funding underpins continued product investment and nationwide scaling.

Market Expansion: The platform reports activity in all 50 states and D.C., rising provider and patient counts, and expansion into Medicare Advantage and Medicaid. Help-center updates and company materials highlight broader coverage and multi‑state credentialing enabling nationwide reach.

Strategic Partnerships: Participation with major insurers (e.g., Aetna, select BCBS plans, Cigna/Evernorth, UnitedHealthcare/Optum) and support from partners like BCBS Massachusetts signal strong payer alignment. These relationships appear to facilitate national scale and access across plan types.

Innovation-Driven Growth: Recent launches of VelocityAI, the Vēlo assistant, and an AI “Hands & Wrists” assessment indicate active R&D and product expansion aimed at upsell and new logo wins. Ongoing product investment supports cross‑sell opportunities and differentiation in core EHS domains.

Strong Market Position & Advantage: Placement as a Verdantix Green Quadrant Leader and a #6 global rank in G2’s 2026 Best Software Awards signal recognized competitive standing and broad customer traction. Third‑party accolades point to perceived leadership and visibility in the market.

Investor Backing & Capital Strength: Long‑term ownership by CVC Growth and a significant minority stake from Partners Group provide sponsor support often used to fund organic growth and M&A. The appointment of a Chief Revenue Officer “to accelerate growth” reflects go‑to‑market scaling supported by governance.

Strong Hiring & Retention: Active, multi‑team openings across Client Experience, Engineering, Product, Operations, and leadership indicate ongoing headcount expansion. Feedback suggests broad hiring aligns with an expansionary near‑term trajectory.

Investor Backing & Capital Strength: Multiple funding rounds from prominent investors are cited, supporting scale‑up and new initiatives. Feedback suggests this capital base underpins continued hiring and vertical expansion.

Market Expansion: Nationwide coverage across disability, workers’ compensation, and VA benefits, along with state‑specific intake pages, points to broad geographic and service reach. Expansion into additional benefit categories indicates a widening addressable market.

Investor Backing & Capital Strength: Recent Series A and Series B financings are cited to fund product development and scale to larger institutions, signaling runway and investor confidence.

Strong Revenue Growth: Company materials and coverage indicate revenues, client count, and monthly accounts have increased meaningfully since the 2022 Series A.

Diversified Customer Base: Named relationships span large credit unions, fintech lenders, banks, card issuers, and debt buyers, suggesting broad enterprise traction across creditor types.

Market Expansion: Recent state reports and program materials show ClassWallet operating ESA, scholarship, and grant/tax-credit programs across numerous states, including Arizona, Arkansas, Indiana, Ohio, the Carolinas, New Hampshire, Idaho, Texas, Georgia, Alabama, Missouri, and Virginia. Updates to vendor lists and program guides into 2026 further indicate ongoing onboarding and operations across these jurisdictions.

Strong Revenue Growth: Company-reported FY2022 results cite booking over $1.1B in business with net revenues more than doubling year over year, alongside triple‑digit transaction volume growth from FY2021. Recognition on successive Inc. 5000 lists in 2022–2024 and a 2023 ranking underscore multi‑year revenue expansion.

Investor Backing & Capital Strength: A $95M growth equity round in 2023 is described as funding to expand reach in public‑fund management and scale product and operations. Such capital, combined with prior growth milestones, supports multi‑year expansion efforts.

Investor Backing & Capital Strength: Feedback suggests recent seed rounds (e.g., Seed III in early 2023) and participation in reputable accelerators signal ongoing access to capital and investor confidence.

Market Expansion: Feedback suggests multi‑state operations, active partner recruitment, and rollouts with health systems indicate geographic and network growth through 2025–2026.

Innovation-Driven Growth: Feedback suggests SOC 2 Type I, a granted patent, and a TAG Top 10 Innovative Company recognition point to product maturation and innovation supporting scale-up.

Investor Backing & Capital Strength: Recent announcements cite a $450M raise in February 2026 to fund up to 10,000 additional U.S. restaurants, with multiple trackers reflecting the facility. Statements also note over $600M deployed to date, indicating a larger funding base.

Strong Revenue Growth: Third-party trackers report 2025 revenue around $350M and company materials highlight multi-year increases in gross order volume. These signals reinforce a larger operating scale than prior years.

Market Expansion: Disclosures reference thousands of partner restaurants, 4M+ users, and broader distribution through channels like Costco. Plans to add 10,000 restaurants and ongoing hiring point to accelerating reach.

Strong Revenue Growth: Independent market research estimates indicate annualized revenue roughly doubled in 2024, pointing to rapid topline expansion into 2025. This trajectory aligns with other scale markers like cumulative sessions growth.

Market Expansion: Company materials describe nationwide therapy and psychiatry availability and 10M+ cumulative sessions by mid‑2026, indicating expanding reach and utilization. Press mentions of 21,000+ licensed providers with next‑day access further underscore capacity growth.

Strategic Partnerships: Recent references to integrations with major insurers and health‑system/employer channels (e.g., Kaiser regions, Stanford Health Care Alliance, Amazon programs) suggest deepening distribution. Active hiring for partnership roles and multiple plan collaborations reinforce go‑to‑market scaling.

Strong Revenue Growth: Reported record revenue for full-year 2025 and a record first quarter in 2026, with management maintaining full-year guidance. Receivables also grew year over year, reinforcing momentum.

Profitability: Full-year 2025 delivered record adjusted net income and GAAP profitability, indicating sustained earnings strength. Management’s 2026 outlook anticipates further adjusted net income growth.

Market Expansion: A planned acquisition of BNCCORP/BNC National Bank is intended to broaden products and geography while reducing funding costs. Simplifying the capital structure to a traditional C‑corp further supports scalability.

Investor Backing & Capital Strength: Recent late‑stage financing of $150M in March 2026 and a reported ~$3B valuation signal strong external capital support and balance‑sheet flexibility. Multiple reputable outlets and independent trackers corroborate the funding milestone and late‑stage status.

Strong Revenue Growth: Trade coverage and company statements cite approximately a $1B annual revenue run rate around the Series D, indicating rapid top‑line expansion. These figures are directional but echoed across multiple reputable sources.

Strategic Partnerships: Expansion of integrations with health plans and new employer offerings points to deepening commercial relationships beyond direct‑to‑consumer. Reports describe broad insurer participation and expanded enterprise distribution.

Investor Backing & Capital Strength: Company communications and ownership updates indicate full acquisition by a long‑term strategic investor, with messaging about continued support for product and go‑to‑market investment. This backing is framed as enabling the next phase of growth.

Product Line Growth: Public materials highlight ongoing feature releases, expanded offerings like a middle‑school science solution, and updated efficacy positioning aligned to funding pathways. These updates suggest an expanding portfolio aimed at deeper district use.

Strong Market Position & Advantage: Go‑to‑market messaging emphasizes broad U.S. district presence, district‑wide subscription focus, and inclusion on large‑district vendor lists. Continued hiring and major conference activity point to sustained market engagement at scale.

Strong Hiring & Retention: Active hiring signals are evident with multiple recent postings across Operations, Engineering, Product, RCM, and Partnerships and a visible “We’re Hiring!” banner. Feedback suggests team size and social followership on LinkedIn are consistent with recent headcount expansion.

Market Expansion: The company markets Medicare-covered virtual psychotherapy “across all 50 states,” indicating a national footprint rather than a limited pilot. Self-described service to “thousands of patients” across many states further reinforces expanding reach.

Innovation-Driven Growth: The organization emphasizes an AI-native platform with real-time clinical insights and clinical copilots to scale care delivery and efficiency. This technology-forward posture supports growth in virtual operations for older adults.

Market Expansion: Public materials indicate the network has expanded to 6,000+ research sites across 50+ countries and 25+ sponsors, up from 5,500+ sites cited in late 2025. This footprint growth signals broader geographic reach and increasing demand-side participation.

Strategic Partnerships: Announced partnerships such as the September 2025 RealTime eClinical data-integration open access to 50+ large site networks (2,000+ sites) and enrich marketplace data. Additional integrations (e.g., eClinPro in 2026) reinforce distribution and embed the platform more deeply in site workflows.

Innovation-Driven Growth: The company launched AI-enabled pre-screening, AI site selection, and EHR integration in 2025–2026 to improve patient identification and sponsor decision-making. These capabilities can increase conversion and make the platform more attractive to both sites and sponsors.

Investor Backing & Capital Strength: Funding announcements show Marble Health raised a $15.5M Series A in October 2025 led by Costanoa with participation from Town Hall Ventures and Khosla Ventures, signaling strong investor support. Company and investor communications indicate this capital is earmarked to scale operations, expand partnerships, and grow the team.

Market Expansion: Company updates indicate launches beyond New York into states like Ohio and New Jersey, pointing to a widening geographic footprint. Public materials also highlight school partnerships and rising therapy-session volumes since launch, consistent with expansion.

Strong Hiring & Retention: Open roles across growth, operations, and product on company and third‑party job boards indicate active team growth. Leadership posts describe go‑to‑market hiring momentum ahead of school years, suggesting sustained scaling efforts.

Investor Backing & Capital Strength: GV led a $28.1M round in February 2023 to scale firsthand’s Medicaid-focused SMI model and multi‑state operations. This capital provides runway supporting ongoing activity despite subsequent turbulence.

Market Expansion: Operations span multiple states (e.g., Florida, Ohio, Michigan, Virginia, Washington) with active postings in 2026, indicating selective growth and continuation in targeted markets. Company materials and social updates point to stabilization and focused re‑entry after 2025 cuts.

Strategic Partnerships: The model centers on payer partnerships in Medicaid, and firsthand is a contracted provider with Molina, aligning offerings with managed‑care needs. Such plan relationships underpin access to attributed lives and contract‑driven revenue.

Market Expansion: Public materials describe broadened operations across major U.S. hubs and international cities, with additional California expansion plans noted in March 2026 coverage. Company channels also reference global pickup coverage across North America, EMEA, and APJ.

Product Line Growth: Recent updates highlight expanded Device Retrievals and a unified, enterprise‑grade lifecycle platform. These feature additions indicate ongoing investment to address a wider range of assets and workflows.

Strong Hiring & Retention: Active recruitment for senior go‑to‑market roles and an updated headcount listing (e.g., 120 employees on Built In in June 2026) signal team expansion. Job descriptions and public posts depict a profitable, rapidly growing business consistent with scaling talent needs.

Market Expansion: The Captionmax and National Captioning Canada acquisition added live services and Canadian reach. A 2025 rebrand positioned the company toward global video localization and accessibility, indicating a broader go‑to‑market.

Product Line Growth: New offerings include a global linguist marketplace and AI‑enabled localization/EAA compliance solutions in 2025, plus an AI dubbing solution for YouTube creators in April 2026. These launches show expansion into adjacent workflows beyond core captioning.

Investor Backing & Capital Strength: Riverside Partners’ 2019 investment provides institutional sponsorship typical of scale‑up platforms. This backing supported organic investment and acquisitions such as Captionmax.